InvestorsHub Logo
Followers 484
Posts 60926
Boards Moderated 18
Alias Born 09/20/2001

Re: Toxic Avenger post# 19288

Sunday, 10/23/2011 8:07:52 PM

Sunday, October 23, 2011 8:07:52 PM

Post# of 56720
Spencer told me what directly? I have no idea what you are referring to.

I have never seen any suggestion that these trials indicated the CareBot was finished and ready to market.

As you quoted and I copy below - this clearly indicates further trials.


"We are routinely asked by potential CareBot™ purchasers and investors: 'How long will you be in trials and how many CareBots do you have in trial?' Unfortunately due to limited resources, we cannot simply spend more money on an as needed basis. So on one hand, while we must remain cognizant of the realities of fund raising during this Great Recession, we are also well aware and routinely reminded of the pent up demand for cost effective home assistance for the elderly and chronically ill.

"Due to the historic nature of these in home trials and our intention to delight our first customers by exceeding their expectations, we will be adding several care receivers with differing levels of autonomy and frailty. Sometimes grandma hears well, speaks clearly and ambulates about her home without any assistance. At another extreme, she may be confined to a wheel chair and incapable of normal verbal interaction.

"I believe that once we have a focus group of fifteen to twenty-five families with their experiences with a CareBot incorporated into their daily lives, we will have a pretty good idea as to what will delight eighty to ninety percent of our target market in elder care. How long it takes us to get to that plateau of understanding and confidence in CareBot safety, security and service is dependent -- in no small part -- on the continued success of our fundraising activities," observed Martin Spencer, President/CEO, GeckoSystems.



In short - good results - need more trials - need funds to conduct trials.

Not too complicated IMO.


Keeping it Real



OTC & Pink DD board.